Pembro + Lenvatinib + CT for GEC
LEAP-015: Phase III Safety Run-in Data With Pembrolizumab + Lenvatinib + Chemotherapy for Advanced Gastroesophageal Cancer

Released: January 25, 2023

Expiration: January 24, 2024

Activity

Progress
1
Course Completed